1. Home
  2. ABEO vs RNGR Comparison

ABEO vs RNGR Comparison

Compare ABEO & RNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • RNGR
  • Stock Information
  • Founded
  • ABEO 1974
  • RNGR 2017
  • Country
  • ABEO United States
  • RNGR United States
  • Employees
  • ABEO N/A
  • RNGR N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • RNGR Oilfield Services/Equipment
  • Sector
  • ABEO Health Care
  • RNGR Energy
  • Exchange
  • ABEO Nasdaq
  • RNGR Nasdaq
  • Market Cap
  • ABEO 256.9M
  • RNGR 279.8M
  • IPO Year
  • ABEO 1980
  • RNGR 2017
  • Fundamental
  • Price
  • ABEO $5.57
  • RNGR $12.07
  • Analyst Decision
  • ABEO Strong Buy
  • RNGR Hold
  • Analyst Count
  • ABEO 6
  • RNGR 2
  • Target Price
  • ABEO $18.00
  • RNGR $12.50
  • AVG Volume (30 Days)
  • ABEO 1.1M
  • RNGR 289.5K
  • Earning Date
  • ABEO 08-11-2025
  • RNGR 07-28-2025
  • Dividend Yield
  • ABEO N/A
  • RNGR 2.01%
  • EPS Growth
  • ABEO N/A
  • RNGR 27.70
  • EPS
  • ABEO N/A
  • RNGR 0.87
  • Revenue
  • ABEO N/A
  • RNGR $569,400,000.00
  • Revenue This Year
  • ABEO N/A
  • RNGR $11.70
  • Revenue Next Year
  • ABEO $323.51
  • RNGR N/A
  • P/E Ratio
  • ABEO N/A
  • RNGR $13.70
  • Revenue Growth
  • ABEO N/A
  • RNGR N/A
  • 52 Week Low
  • ABEO $3.93
  • RNGR $9.92
  • 52 Week High
  • ABEO $7.32
  • RNGR $18.45
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 37.51
  • RNGR 43.23
  • Support Level
  • ABEO $5.66
  • RNGR $11.93
  • Resistance Level
  • ABEO $6.24
  • RNGR $12.44
  • Average True Range (ATR)
  • ABEO 0.26
  • RNGR 0.38
  • MACD
  • ABEO -0.08
  • RNGR -0.09
  • Stochastic Oscillator
  • ABEO 8.08
  • RNGR 6.49

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About RNGR Ranger Energy Services Inc.

Ranger Energy Services Inc is a provider of onshore high-specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well-site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions, and Ancillary Services, of which key revenue is derived from the High Specification Rigs segment.

Share on Social Networks: